ArticleYonsei medical journal2026
Screening and Predictive Value of Thoracic Ossification Observed on Lateral Radiography for Myelopathy.
Article in Yonsei medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeOssification of the ligamentum flavum (OLF) is known to compress neural structures, leading to myelopathy. Although computed tomography (CT) is a reliable diagnostic tool, thoracic OLF is often underdiagnosed due to the challenges of routinely performing thoracic imaging in clinical practice. Radiographs offer a more accessible option but lack established criteria for screening clinically significant thoracic OLF. MATERIALS AND
methodsRetrospective study conducted at a single institution, evaluating radiographic and clinical data from patients with thoracic OLF. A total of 142 patients were included: 69 in the myelopathy group, who had myelopathy symptoms due to thoracic OLF, and 73 in the non-myelopathy group, who had OLF observed on CT but no myelopathy symptoms.
resultsThe OLF diameter (8.39±2.42 mm vs. 5.96±2.93 mm,
conclusionThe OLF diameter ratio measured on lateral radiographs is an effective and non-invasive parameter for identifying thoracic OLF cases with myelopathy symptoms. When the OLF diameter ratio is ≥0.58, clinicians should consider the possibility of myelopathy and perform further diagnostic imaging, such as CT or magnetic resonance imaging, to guide treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.